Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00351858
Status:
TERMINATED
Last Update Posted:
2015-05-01
First Post:
2006-07-12
Brief Title:
Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer
Sponsor:
Organization:
Neovii Biotech